InnovAge (OTCMKTS:INNV) Stock Crosses Below 50-Day Moving Average – Should You Sell?

InnovAge Holding Corp. (OTCMKTS:INNVGet Free Report)’s share price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $5.84 and traded as low as $4.87. InnovAge shares last traded at $4.97, with a volume of 35,819 shares traded.

InnovAge Stock Down 5.5 %

The stock has a market cap of $673.21 million, a price-to-earnings ratio of -41.42 and a beta of 0.39. The firm’s 50 day moving average is $5.84 and its two-hundred day moving average is $5.47. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.25.

InnovAge (OTCMKTS:INNVGet Free Report) last posted its quarterly earnings data on Tuesday, September 10th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.01. The business had revenue of $199.40 million during the quarter, compared to analyst estimates of $190.19 million. InnovAge had a negative net margin of 6.17% and a negative return on equity of 13.04%. On average, sell-side analysts predict that InnovAge Holding Corp. will post -0.25 EPS for the current year.

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Recommended Stories

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.